If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Pollen Street Secured Lending PLC)

20 Aug 2020 12:50

RNS Number : 7398W
Honeycomb Investment Trust PLC
20 August 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Honeycomb Investment Trust plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Pollen Street Secured Lending plc ("PSSL")

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

19 August 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Honeycomb Investment Trust plc ("HIT")

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a). Interests of PDMRs of Pollen Street Capital Limited in PSSL's ordinary shares of £0.01 each:

 

PDMR

Number of ordinary shares

% of voting rights (1)

Lindsey McMurray(2)

316,915

0.43

Matthew Potter

35,277

0.05

Steve Plowman(3)(4)

 

21,925

0.03

Michael England

18,903

0.03

Ian Gascoigne

18,890

0.03

 

(1) Pursuant to the Rule 2.9 announcement made by PSSL on 20 August 2020, as at 19 August 2020 PSSL had 86,306,803 ordinary shares of £0.01 each in issue, of which 12,586,576 ordinary shares were held in treasury. The total number of voting rights in PSSL was therefore 73,720,227.

(2) Shares are held jointly by Lindsey McMurray and her husband.

(3) Steve Plowman is a previous PDMR of Pollen Street Capital Limited.

(4) Shares held indirectly through Hap Limited, a private limited company jointly owned by Steve Plowman and his wife.

 

b). Interests of persons presumed to be acting in concert with HIT in PSSL's ordinary shares of £0.01 each:

 

Shareholder

Number of ordinary shares owned and/or controlled (2)

% of voting rights (1)

Quilter plc (and its subsidiaries)(2)

14,874,420

20.18

 

(1) Pursuant to the Rule 2.9 announcement made by PSSL on 20 August 2020, as at 19 August 2020 PSSL had 86,306,803 ordinary shares of £0.01 each in issue, of which 12,586,576 ordinary shares were held in treasury. The total number of voting rights in PSSL was therefore 73,720,227.

(2) Information relating to Quilter plc's ("Quilter") interests in PSSL's securities has been taken from the latest dealing disclosure made by Quilter on 18 August 2020 in respect of PSSL securities.

(3) Under the UK Takeover Code, Quilter is presumed to be acting in concert with HIT as it has ownership or control of 20 per cent. or more of HIT's equity share capital.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

20 August 2020

Contact name:

Tom O'Neill

Telephone number:

+(44) 203 728 6750

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEDZGZRMGDGGZM
Date   Source Headline
7th Oct 20227:00 amRNSChange of Name
5th Oct 20225:11 pmRNSHolding(s) in Company
5th Oct 20225:11 pmRNSHolding(s) in Company
5th Oct 20225:07 pmRNSHolding(s) in Company
5th Oct 20225:04 pmRNSHolding(s) in Company
5th Oct 202212:01 pmRNSDirector/PDMR Shareholding
4th Oct 20226:23 pmRNSHolding(s) in Company
4th Oct 20225:44 pmRNSHolding(s) in Company
4th Oct 20225:10 pmRNSHolding(s) in Company
4th Oct 20224:53 pmRNSHolding(s) in Company
4th Oct 202212:07 pmRNSHolding(s) in Company
4th Oct 202211:29 amRNSHolding(s) in Company
30th Sep 20228:12 amRNSCompletion of the Combination with Pollen Street
26th Sep 20222:40 pmRNSPublication of a Prospectus
14th Sep 20224:44 pmRNSChange Of Latest DRIP Election Date
13th Sep 20227:45 amRNSHalf-year Report
6th Sep 20221:48 pmRNSDividend Declaration
6th Sep 20227:00 amRNSNAV and Monthly Update - July 2022
3rd Aug 20227:00 amRNSMonthly Update - June 2022
25th Jul 20227:00 amRNSAppointment of Corporate Broker
29th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20227:00 amRNSNAV and Monthly Update - May 2022
22nd Jun 20224:12 pmRNSResult of AGM
22nd Jun 20227:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jun 20224:10 pmRNSResults of General Meeting
26th May 20227:00 amRNSNAV and Monthly Update – April 2022.
18th May 20224:22 pmRNSPosting of Annual Report and Notice of AGM
18th May 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
10th May 20222:36 pmRNSCircular and Notice of General Meeting
6th May 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20227:00 amRNSShare Buyback Programme Extension
27th Apr 20227:00 amRNSMonthly Update - March 2022
26th Apr 20224:34 pmRNSDividend Declaration
7th Apr 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20227:01 amRNSTransaction in Own Shares
21st Mar 20227:00 amRNSMonthly Update - February 2022
11th Mar 20223:21 pmRNSRussian Exposure
2nd Mar 20227:01 amRNSAnnual Financial Report
2nd Mar 20227:00 amRNSStatement re Share Buyback
2nd Mar 20227:00 amRNSCapital Markets Day
24th Feb 20227:00 amRNSNotice of upcoming Capital Markets Event
23rd Feb 20222:34 pmRNSDirector Declaration
23rd Feb 20222:28 pmRNSDividend Declaration
15th Feb 20227:00 amRNSHoneycomb combination with Pollen Street Capital
31st Jan 20227:00 amRNSMonthly Update - December 2021
23rd Dec 20217:00 amRNSNAV and Monthly Update - November 2021
24th Nov 20211:13 pmRNSDividend Declaration
23rd Nov 20217:00 amRNSNAV and Monthly Update - October 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.